Biomemory launches DNA Shield, its first commercial product on the Molecular IT platform
Biomemory has launched DNA Shield, the first commercial product built on its Molecular IT platform. The launch follows Biomemory's acquisition of catalog's assets and the appointment of Laurent Guengant as CEO earlier this year. The article is product and business news. It describes no vulnerability, incident, threat actor or indicator, a…